AVEO Pharma
AcquiredPassionately pursuing a better life for patients with cancer.
Cambridge, United States · Founded 2003 · $53.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2003
- Business Model
- B2B
- Total Funding
- $53.0M
- Last Round
- $53.0M Series DApr 2007
- Rounds
- 4
- Acquisition Date
- Nov 2022
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
AVEO, in partnership with LG Chem, is on a mission to help those with cancer move forward with treatment that is effective and allows them to carry on with their daily lives. AVEO will oversee US late-stage clinical development, leveraging LG Chem's resources and technology to facilitate commercialization of new anti-cancer drugs. Operating as an LG Chem company allows AVEO to leverage the strengths of a global presence in the industry.
Summary
AVEO Pharma is a Biotech company based in Cambridge, United States, founded in 2003. It has raised $53.0M in total across 4 rounds, most recently a $53.0M Series D round in Apr 2007. Investors include Bessemer Venture Partners, Merlin BioMed Group and Biogen.
Funding & Exit History
Nov 2022
Sign up to see all 7 events
Funding: Series A through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aveo-pharma"><img src="https://indexed.vc/api/badge/company/aveo-pharma" alt="AVEO Pharma on Indexed.vc" width="260" height="76" /></a>